BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 2969275)

  • 1. Effect of chronic ethanol treatment on dopamine receptor subtypes in rat striatum.
    Lucchi L; Moresco RM; Govoni S; Trabucchi M
    Brain Res; 1988 May; 449(1-2):347-51. PubMed ID: 2969275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age related differences in dopamine-stimulated adenylate cyclase sensitivity to "in vivo" chronic ethanol treatment.
    Lucchi L; Govoni S; Trabucchi M
    Alcohol; 1984; 1(4):263-7. PubMed ID: 6100231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective blockade of dopamine D-1 receptors by SCH 23390 discloses striatal dopamine D-2 receptors mediating the inhibition of adenylate cyclase in rats.
    Onali P; Olianas MC; Gessa GL
    Eur J Pharmacol; 1984 Mar; 99(1):127-8. PubMed ID: 6233165
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of chronic ethanol treatment on adenylate cyclase activity in rat striatum.
    Lucchi L; Covelli V; Anthopoulou H; Spano PF; Trabucchi M
    Neurosci Lett; 1983 Sep; 40(2):187-92. PubMed ID: 6314211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential modulation of D1 and D2 dopamine-sensitive adenylate cyclases by 17 beta-estradiol in cultured striatal neurons and anterior pituitary cells.
    Maus M; Bertrand P; Drouva S; Rasolonjanahary R; Kordon C; Glowinski J; Premont J; Enjalbert A
    J Neurochem; 1989 Feb; 52(2):410-8. PubMed ID: 2521359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ethanol administration of striatal D1 and D2 dopamine receptors.
    Hruska RE
    J Neurochem; 1988 Jun; 50(6):1929-33. PubMed ID: 2967351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P; Olianas MC; Gessa GL
    Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of the function of D1 and D2 dopamine receptors in striatum and nucleus accumbens of rats chronically treated with haloperidol.
    Memo M; Pizzi M; Missale C; Carruba MO; Spano PF
    Neuropharmacology; 1987 May; 26(5):477-80. PubMed ID: 2955241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striatal adenylate cyclase-inhibiting dopamine D2 receptors are not affected by the aging process.
    Missale C; Castelletti L; Pizzi M; Memo M; Carruba MO; Spano PF
    Neurosci Lett; 1987 Mar; 75(1):38-42. PubMed ID: 3033556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleep deprivation increases dopamine D1 receptor antagonist [3H]SCH 23390 binding and dopamine-stimulated adenylate cyclase in the rat limbic system.
    Demontis MG; Fadda P; Devoto P; Martellotta MC; Fratta W
    Neurosci Lett; 1990 Sep; 117(1-2):224-7. PubMed ID: 2149748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethanol administration does not alter dopamine D1 and D2 receptor characteristics in rat brain.
    Hietala J; Salonen I; Lappalainen J; Syvälahti E
    Neurosci Lett; 1990 Jan; 108(3):289-94. PubMed ID: 2137566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postnatal development of striatal dopamine function. I. An examination of D1 and D2 receptors, adenylate cyclase regulation and presynaptic dopamine markers.
    Broaddus WC; Bennett JP
    Brain Res Dev Brain Res; 1990 Mar; 52(1-2):265-71. PubMed ID: 2331795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine receptors in canine caudate nucleus.
    Maeno H
    Mol Cell Biochem; 1982 Mar; 43(2):65-80. PubMed ID: 6123940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ceruletide on perioral movements and the dopamine receptor-adenylate cyclase system in rats chronically treated with fluphenazine.
    Ashizawa T; Saito T; Takahata N
    Psychopharmacology (Berl); 1996 Jun; 125(3):185-94. PubMed ID: 8815952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D2 dopamine receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in rat striatum.
    Battaglia G; Norman AB; Hess EJ; Creese I
    Neurosci Lett; 1985 Aug; 59(2):177-82. PubMed ID: 2932659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for different states of the dopamine D1 receptor: clozapine and fluperlapine may preferentially label an adenylate cyclase-coupled state of the D1 receptor.
    Andersen PH; Braestrup C
    J Neurochem; 1986 Dec; 47(6):1822-31. PubMed ID: 2945903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dopamine receptor adenylate cyclase complex: evidence for post recognition site involvement for the development of supersensitivity.
    Parenti M; Gentleman S; Olianas MC; Neff NH
    Neurochem Res; 1982 Jan; 7(1):115-24. PubMed ID: 7070577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cocaine administration: D1 dopamine receptor function and dopamine clearance/diffusion in rat striatum and nucleus accumbens.
    Zahniser NR; Mayfield RD; Cass WA; Gerhardt GA
    Ann N Y Acad Sci; 1992 Jun; 654():537-9. PubMed ID: 1385936
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of aging on striatal dopamine receptor subtypes in Wistar rats.
    Henry JM; Filburn CR; Joseph JA; Roth GS
    Neurobiol Aging; 1986; 7(5):357-61. PubMed ID: 2946969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of D1 and D2 dopamine receptors in rat limbocortical areas. II. Dorsal hippocampus.
    Grilli M; Nisoli E; Memo M; Missale C; Spano PF
    Neurosci Lett; 1988 May; 87(3):253-8. PubMed ID: 2898118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.